Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Joseph Glorioso
Ohio State University, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Oncorus
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Glorioso’s conflict arises due to his interest as an inventor of the intellectual property being evaluated/developed under bench research funded by this grant, which the University of Pittsburgh licensed to Oncorus. Dr. Glorioso also consults for Oncorus and will be in receipt of stock options and cash compensation for his services.
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
RELEVANCE: oHSV-based clinical trials of malignant gliomas have been well tolerated by humans, but more work is required to enhance the efficacy of the treatment. This program project will characterize fundamental barriers and host responses that are deleterious to the efficacy of oHSV and will provide solutions that will increase oHSV therapeutic effectiveness, while maintaining its current record of safety.
Filed on June 30, 2016.
Tell us what you know about Joseph Glorioso's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Joseph Glorioso”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Joseph Glorioso | Ohio State University | Conflict of Interest | Oncorus | Value cannot be readily determined |
| Joseph Glorioso | Ohio State University | Conflict of Interest | Oncorus | $100,000 - $149,999 |
| Joseph Glorioso | University of Pittsburgh at Pittsburgh | Conflict of Interest | Oncorus, Inc. | Value cannot be readily determined |
| Joseph Glorioso | University of Pittsburgh at Pittsburgh | Conflict of Interest | Oncorus, Inc. | $100,000 - $149,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.